Top

Published in:

01-08-2008 | Original Article

Promoting Access to Renal Transplantation: The Role of Social Support Networks in Completing Pre-transplant Evaluations

Authors: Cheryl R. Clark, MD, SD, Leroi S. Hicks, MD, MPH, Joseph H. Keogh, MD, JD, Arnold M. Epstein, MD, John Z. Ayanian, MD, MPP

Published in: Journal of General Internal Medicine | Issue 8/2008

Abstract

Background

Completing pre-transplant evaluations may be a greater barrier to renal transplantation for blacks with end-stage renal disease (ESRD) than for whites.

Objective

To determine whether social support networks facilitate completing the pre-transplant evaluation and reduce racial disparities in this aspect of care.

Design, Setting, and Participants

We surveyed 742 black and white ESRD patients in four regional networks 9 months after they initiated dialysis in 1996 and 1997. Patients reported instrumental support networks (number of friends or family to help with daily activities), emotional support networks (number of friends or family available for counsel on personal problems) and dialysis center support (support from dialysis center staff and patients). The completion of pre-transplant evaluations, including preoperative risk stratification and testing, was determined by medical record reviews.

Outcome Measurement

Complete renal pre-transplant evaluations.

Results

Compared to patients with low levels of instrumental support, those with high levels were more likely to have complete evaluations (25% versus 46%, respectively, p < .001). In adjusted analyses, high levels of instrumental support were associated with higher rates of complete evaluations among black women (p < .05), white women (p < .05), and white men (p < .05), but not black men. Among black men, but not other groups, private insurance was a significant predictor of complete evaluations.

Conclusions

Instrumental support networks may facilitate completing renal pre-transplant evaluations. Clinical interventions that supplement instrumental support should be evaluated to improve access to renal transplantation. Access to supplemental insurance may also promote complete evaluations for black patients.

Available only for authorised users

Smedley B, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington DC: The National Academies Press, 2003.

Epstein AM, Ayanian JZ, Keogh JH, et al. Racial disparities in access to renal transplantation—clinically appropriate or due to underuse or overuse? N Engl J Med. 2000;343(21):1537–44.PubMedCrossRef

Peterson ED, Shaw LK, DeLong ER, Pryor DB, Califf RM, Mark DB. Racial variation in the use of coronary-revascularization procedures. Are the differences real? Do they matter? N Engl J Med. 1997;336(7):480–6.PubMedCrossRef

Cameron JI, Whiteside C, Katz J, Devins GM. Differences in quality of life across renal replacement therapies: a meta-analytic comparison. Am J Kidney Dis. 2000;35(4):629–37.PubMedCrossRef

Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725–30.PubMedCrossRef

Eggers PW. Racial differences in access to kidney transplantation. Health Care Financ Rev. 1995;17(2):89–103.PubMed

Alexander GC, Sehgal AR. Barriers to cadaveric renal transplantation among blacks, women, and the poor. JAMA. 1998;280(13):1148–52.PubMedCrossRef

Gaylin DS, Held PJ, Port FK, Hunsicker LG, Wolfe RA, Kahan BD, et al. The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA. 1993;269(5):603–8.PubMedCrossRef

Weng FL, Joffe MM, Feldman HI, Mange KC. Rates of completion of the medical evaluation for renal transplantation. Am J Kidney Dis. 2005;46(4):734–45.PubMedCrossRef

10.

Ayanian JZ, Cleary PD, Weissman JS, Epstein AM. The effect of patients’ preferences on racial differences in access to renal transplantation. N Engl J Med. 1999;341(22):1661–9.PubMedCrossRef

11.

Alexander GC, Sehgal AR. Why hemodialysis patients fail to complete the transplantation process. Am J Kidney Dis. 2001;37(2)321–8.PubMedCrossRef

12.

Kasiske BL, Cangro CB, Hariharan S, et al. The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant. 2001;1(Suppl 2):3–95.PubMed

13.

Steinman TI, Becker BN, Frost AE, Olthoff KM, Smart FW, Suki WN, et al. Guidelines for the referral and management of patients eligible for solid organ transplantation. Transplantation. 2001;71(9):1189–204.PubMedCrossRef

14.

Ayanian JZ, Cleary PD, Keogh JH, Noonan SJ, David-Kasdan JA, Epstein AM. Physicians’ beliefs about racial differences in referral for renal transplantation. Am J Kidney Dis. 2004;43(2):350–7.PubMedCrossRef

15.

Arthur T. The role of social networks: a novel hypothesis to explain the phenomenon of racial disparity in kidney transplantation. Am J Kidney Dis. 2002;40(4):678–81.PubMedCrossRef

16.

Hicks LS, Cleary PD, Epstein AM, Ayanian JZ. Differences in health-related quality of life and treatment preferences among black and white patients with end-stage renal disease. Qual Life Res. 2004;13(6):1129–37.PubMedCrossRef

17.

Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res. 1994;3(5):329–38.PubMedCrossRef

18.

Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol. 2006;59(10):1087–91.PubMedCrossRef

19.

Woloshin S, Schwartz LM, Tosteson AN, et al. Perceived adequacy of tangible social support and health outcomes in patients with coronary artery disease. J Gen Intern Med. 1997;12(10):613–8.PubMedCrossRef

20.

Becker G, Gates RJ, Newsom E. Self-care among chronically ill African Americans: culture, health disparities, and health insurance status. Am J Public Health. 2004;94(12):2066–73.PubMed

21.

Centers for Disease Control and Prevention. Kidney disease mortality—Michigan, 1989–2005. Morb Mort Wkly Rep. 2007;56(10):225–27.

22.

Grubbs V. Good for harvest, bad for planting. Health Aff. (Millwood). 2007;26(1):232–7.CrossRef

23.

Holley JL, McCauley C, Doherty B, Stackiewicz L, Johnson JP. Patients’ views in the choice of renal transplant. Kidney Int. 1996;49(2):494–8.PubMedCrossRef

24.

Klassen AC, Hall AG, Saksvig B, Curbow B, Klassen DK. Relationship between patients’ perceptions of disadvantage and discrimination and listing for kidney transplantation. Am J Public Health. 2002;92(5):811–7.PubMedCrossRef

25.

Dohan D, Schrag D. Using navigators to improve care of underserved patients: current practices and approaches. Cancer. 2005;104(4):848–55.PubMedCrossRef

26.

Patel SS, Peterson RA, Kimmel PL. The impact of social support on end-stage renal disease. Semin Dial. 2005;18(2):98–102.PubMedCrossRef

27.

Magee CC, Pascual M. Update in renal transplantation. Arch Intern Med. 2004;164(13):1373–88.PubMedCrossRef

28.

Young CJ, Gaston RS. Renal transplantation in black Americans. N Engl J Med. 2000;343(21):1545–52.PubMedCrossRef

Title: Promoting Access to Renal Transplantation: The Role of Social Support Networks in Completing Pre-transplant Evaluations
Authors: Cheryl R. Clark, MD, SD
Leroi S. Hicks, MD, MPH
Joseph H. Keogh, MD, JD
Arnold M. Epstein, MD
John Z. Ayanian, MD, MPP
Publication date: 01-08-2008
Publisher: Springer-Verlag
Published in: Journal of General Internal Medicine / Issue 8/2008
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-008-0628-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Objective

Design, Setting, and Participants

Outcome Measurement

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2008

A Review of Interventions and System Changes to Improve Time to Reperfusion for ST-Segment Elevation Myocardial Infarction

Preparing for an Epidemic of Limited Health Literacy: Weathering the Perfect Storm

Communicating About Alcohol Consumption to Nonharmful Drinkers with Hepatitis C: Patient and Provider Perspectives

External Medicine

Does a History of Non-Vertebral Fracture Identify Women Without Osteoporosis for Treatment?

Redefining and Redesigning Hospital Discharge to Enhance Patient Care: A Randomized Controlled Study

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials